Vol 283, No. 15, 1967-75.
Hypertension is associated with a significantly increased risk of morbidity and mortality.
In January 2000, after an interim analysis, an independent data review committee recommended discontinuing the doxazosin treatment arm based on comparisons with chlorthalidone. Therefore, outcomes data presented herein reflect follow-up through December 1999. Median follow-up was 3.3 years. The University of Minnesota is an equal opportunity educator and employer. The views and opinions expressed in this page are strictly those of the page author.